stocksPRIVISCL
PRIVISCL

Privi Speciality Chemicals Ltd.

3,624.00+76.4 (+2.15%)
9 Jul, 3:29 PM

Income Statement

Abridged
Understanding Income Statement
Privi Speciality Chemicals Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
C
2012
Mar 31
2013
Mar 31
C
2014
Mar 31
2015
Mar 31
2016
Mar 31
R
2017
Mar 31
2018
Mar 31
2019
Mar 31
R
2020
Mar 31
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
IR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
PRESS
Total Revenue
971231521511525971,0241,3411,3241,2771,4041,6081,7522,1012,564
Cost of Operating Revenue
781011101151164647859588609051,0161,2341,2861,4341,635
Gross Profit
1922423636133239383464372388374467667929
Gross Margin
19.318.227.923.823.622.323.328.635.129.127.623.326.631.736.2
Total Operating Expenses
841081211281325559371,1681,1641,1401,2851,5301,5501,7792,061
Operating Profit
1315312320428717316013711978202322502
Operating Margin
13.112.220.115.013.37.18.512.912.110.78.54.911.515.319.6
Financing Income/(Expense) - Net
-2-2-2-2-4-8-9-24-34-26-49-77-73-82
Profit before Taxes
1113282117367915219315813331130255440
Income Taxes
34107682657474135103470123
Profit after Tax
78191411275394146117972295187328
PAT Margin
7.66.812.39.17.04.55.27.011.09.26.91.45.48.912.8
EPS - Basic - ex Extraordinary Items
5.885.5713.549.927.688.8613.6524.1337.5429.9324.935.6924.3047.8783.85
EPS - Diluted - ex Extraordinary Items
5.885.5713.549.927.688.8613.6524.1337.5429.9324.935.6924.3047.8783.85
EBIT
1315312320428717316013711978202322502
EBITDA
151733252369130220217208194187332457646
EBITDA Margin
15.114.021.816.515.311.612.716.416.416.313.811.619.021.825.2

Balance Sheet

Abridged
Understanding Balance Sheet
Privi Speciality Chemicals Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
C
2012
Mar 31
2013
Mar 31
2014
Mar 31
R
2015
Mar 31
R
2016
Mar 31
C
2017
Mar 31
C
2018
Mar 31
2019
Mar 31
R
2020
Mar 31
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Source:
AR
AR
AR
AR
IR
AR
AR
AR
IR
AR
AR
AR
AR
AR
PRESS
Total Current Assets
26304336344855418017287001,0531,2021,1421,3631,596
Long-Term Investments
-----11--1---1124
Property Plant & Equipment - Net
27284469794084805846217651,0621,1011,1131,2731,459
Total Non-Current Assets
29294570804545126256568401,1231,1891,2011,4271,574
Total Assets
5460881051149391,0531,4261,3841,5402,1762,3912,3432,7913,170
Total Current Liabilities
21202928324104576305134549291,1018961,1031,093
Long Term Debt
65714126677181232336397417463521581
Total Non-Current Liabilities
10911202089107220258364428454505569637
Total Liabilities
31294049514995658507728181,3561,5561,4011,6731,729
Total Shareholders' Equity
24314757634404885766127238128299241,1031,412
Minority Interest
----------76171428
Total Equity
24314757634404885766127238208359411,1181,441
Total Liabilities & Equity
5460881051149391,0531,4261,3841,5402,1762,3912,3432,7913,170

Cash Flow

Abridged
Understanding Cash Flow Statement
Privi Speciality Chemicals Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
2012
Mar 31
C
2013
Mar 31
2014
Mar 31
R
2015
Mar 31
2016
Mar 31
R
2017
Mar 31
C
2018
Mar 31
2019
Mar 31
2020
Mar 31
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
PRESS
Operating CF bef Changes in Working Cap
8.7911.7323.3817.4017.1747.20102.14168.56208.02202.35164.60136.01219.31335.98480.16
Working Capital - Increase/(Decrease)
-7.93-2.18-13.7711.95-4.78-46.11-18.45-179.95-0.24-51.54-193.94-153.6740.74-138.56-9.31
Net CF from Operating Activities
0.859.559.6129.3512.381.0983.69-11.39207.78150.81-29.34-17.66260.05197.42470.85
Capital Expenditures - Net
6.975.1119.0825.5113.1371.1092.37168.99210.61242.78308.49139.62142.31298.45320.01
Net CF from Investing Activities
-6.97-5.11-19.08-25.51-13.13-68.57-82.54-139.32-206.64-241.99-320.76-133.46-180.65-295.83-358.54
Dividends Paid - Cash - Total
----3.454.154.536.8011.775.867.817.81-7.8119.53
Debt - LT & ST - Issuance/(Retirement) - Total
7.00-3.4010.81-1.664.89-68.148.67161.6879.1227.78375.11146.81-85.66132.00-122.94
Net Cash Flow from Financing Activities
5.89-4.509.49-3.810.80-72.294.14154.8567.3521.92367.29139.00-75.86124.19-117.97
Free Cash Flow to Equity
0.881.041.342.194.14-138.16-0.02-18.7076.29-64.1937.28-10.4632.0830.9727.90
Free Operating CF net dividend
-6.253.59-9.483.83-4.64-74.62-13.31-187.33-14.65-97.84-345.78-165.16109.54-109.53131.30
Free Operating CF
-6.253.59-9.483.83-1.20-70.47-8.78-180.53-2.88-91.98-337.96-157.35109.54-101.72150.83

Business Segment Analysis

FY End:
Mar 25

Privi Speciality Chemicals Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex
Total₹ 299Cr
Aroma Chemical (100.0%)₹ 299.14 Cr
Revenue / Sales
Total₹ 2,101Cr
Aroma Chemical (100.0%)₹ 2,101.19 Cr
Assets
Total₹ 2,791Cr
Aroma Chemical (100.0%)₹ 2,790.51 Cr
Operating Income
Total₹ 322Cr
Aroma Chemical (100.0%)₹ 321.95 Cr

Regional Segment Analysis

FY End:
Mar 25

Privi Speciality Chemicals Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales
Total₹ 2,092Cr
Outside india (38.8%)₹ 812.32 CrIndia (30.0%)₹ 627.21 CrUnited States of America (19.1%)₹ 400.32 CrSwitzerland (12.0%)₹ 251.92 Cr

Historical Segment Analysis

Track how Privi Speciality Chemicals Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Business
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
Aroma Chemical243309140151299

Frequently Asked Questions

What is the revenue of Privi Speciality Chemicals Ltd.?
The latest trailing twelve month revenue of Privi Speciality Chemicals Ltd. is ₹ 2,563.69 Cr, reflecting a 1-year growth of 22.01% and a 3-year CAGR of 16.83%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Privi Speciality Chemicals Ltd.?
The latest trailing twelve month net profit (PAT) of Privi Speciality Chemicals Ltd. is ₹ 327.54 Cr, with a 3-year earnings CAGR of 145.21%. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Privi Speciality Chemicals Ltd.?
The trailing twelve month EBITDA of Privi Speciality Chemicals Ltd. is approximately ₹ 502.42 Cr (based on an operating margin of 19.60%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Privi Speciality Chemicals Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Privi Speciality Chemicals Ltd. is 83.85. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Privi Speciality Chemicals Ltd.?
The debt-to-equity ratio of Privi Speciality Chemicals Ltd. stands at 0.72. The interest coverage ratio is 6.13x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Privi Speciality Chemicals Ltd.?
The estimated book value per share of Privi Speciality Chemicals Ltd. is 369.36 (derived from a P/B ratio of 9.81 and market price of ₹ 3,624.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Privi Speciality Chemicals Ltd.?
The trailing twelve month operating cash flow of Privi Speciality Chemicals Ltd. is ₹ 470.85 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Privi Speciality Chemicals Ltd. report consolidated or standalone financials?
Privi Speciality Chemicals Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.